NCT05908006View on ClinicalTrials.gov

Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

December 30, 2023

Study Completion Date

January 31, 2024

Conditions
Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions
DEVICE

Velacur

Imaging Procedures Comparison

Trial Locations (2)

39232

GI Alliance-Flowood, MS, Flowood

77598

GI Alliance-Webster, TX, Webster

Sponsors

Lead Sponsor

GI Alliance
All Listed Sponsors
collaborator

Sonic Incytes

INDUSTRY

lead

GI Alliance

OTHER

NCT05908006 - Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease | Biotech Hunter | Biotech Hunter